Imagine a microscopic-scale missile system designed to hunt down and destroy rogue cancer cells one by one, while leaving healthy tissue completely untouched. That is the revolutionary promise of targeted alpha therapy, a cutting-edge field of medicine using specialized radioactive particles. By attaching these powerful alpha emitters to targeting molecules, doctors can deliver localized radiation […]
Archive for July 30th, 2026
A microscopic-scale missile system designed to hunt down and destroy rogue cancer cells
Posted by Michael A. S. Guth on July 30th, 2026
Successful integration of Lead-212-targeted alpha therapy into routine clinical practice
Posted by Michael A. S. Guth on July 30th, 2026
Targeted alpha therapy (TAT) represents a transformative shift in precision oncology, offering high linear energy transfer over extremely short cellular paths to eradicate treatment-resistant malignancies. However, translating these powerful radioisotopes from the bench to the bedside introduces complex operational and toxicological bottlenecks. Chief among these is the management of transient daughter radionuclides like Lead-212 and […]



Posted in